Records containing: In-stent Coronary Artery Restenosis

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2024-05-17
SOLEMN Study - Synergy Optical Coherence Tomography in Left Main PCI
CLINICAL_TRIALS study record update · 2023-02-14
A Prospective, Randomized, Multi-center IDE Study to Assess the SeQuent Please ReX Drug Coated PTCA Balloon Catheter for the Treatment of In-stent Restenosis (RESPECT-ISR)
CLINICAL_TRIALS study record update · 2020-02-25
Classification of Bifurcation Restenosis: a Prognostic Assessment
CLINICAL_TRIALS study record update · 2015-08-19
A Prospective Randomized Comparison of the BioFreedom Biolimus A9 Drug Coated Stent Versus the Gazelle Bare Metal Stent in Patients With High Risk of Bleeding.
CLINICAL_TRIALS study record update · 2015-04-08
Assessment of the Safety and Efficacy of the Danubio Paclitaxel-Eluting Balloon for the Treatment of In-Stent Restenosis Lesions in Native Coronary Arteries.
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2014-08-11
Intra-stent Tissue Evaluation Within BMS and DES > 3 Years Since Implantation
CLINICAL_TRIALS study record update · 2013-05-03
Paclitaxel Releasing Balloon in Patients Presenting With In-Stent Restenosis A Prospective, Multi-centre, Non-randomized Clinical Trial With Follow-up Investigations at 1, 6 and 12 Months
CLINICAL_TRIALS study record update · 2011-02-15
The Rate of In-stent Restenosis Within Bare Metal Stents as Compared to Drug Eluting Stents in Patients With Patent Previously Deployed Bare Metal Stent